When your COPD treatment isn't enough: 5 signs to talk to your doctor

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Yahoo

FDA approves new COPD drug developed by firm in Raleigh. First new treatment in a decade

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...
The American Journal of Managed Care

Assessing Patient-Reported Treatment Values in COPD

Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management. Chronic obstructive ...
European Medical Journal

COPD Treatment Withdrawal Raises Early Exacerbation Risk

New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation ...
Hosted on MSN

Ohtuvayre: The First Novel COPD Treatment Approved in Over a Decade

Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...
WebMD

What Are the Treatments for COPD?

Chronic obstructive pulmonary disease (COPD) makes it hard to breathe. Narrowed airways can make you cough, wheeze, and feel short of breath. It can affect how you exercise, work, and do other daily ...
The American Journal of Managed Care

Evaluating Treatment Options for COPD

AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...
Healio

Asthma patients who smoke may benefit from COPD treatment

Please provide your email address to receive an email when new articles are posted on . Remodeling may include more smooth muscle mass and epithelial cell shedding. Macrolides, vaccination and ...
Healio

Even with treatment, patients with COPD regularly become frequent exacerbators

Please provide your email address to receive an email when new articles are posted on . During a 5-year period, 45,079 of 156,462 patients with GOLD A/B COPD progressed to GOLD E. More patients moved ...
Healthline

What’s the Difference Between COPD and Acute Bronchitis?

Chronic obstructive pulmonary disease (COPD) and acute bronchitis both cause lung irritation and inflammation. They can trigger similar symptoms, including coughing, chest pain, and fatigue. Acute ...
WebMD

What Are the Treatments for COPD?

In addition, symptoms and effective treatments can change quite a bit as the disease gets worse, so it’s good to stay vigilant and check in with your doctor on a regular basis. Wherever you are on ...